Price (delayed)
$0.67
Market cap
$136.15M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.62
Enterprise value
$108.38M
Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies. Spectrum has a strong track record of successfully executing across the biopharmaceutical business
There are no recent dividends present for SPPI.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.